Alnylam Pharmaceuticals, Inc. (0HD2.L)

USD 243.84

(-0.72%)

Total Debt Summary of Alnylam Pharmaceuticals, Inc.

  • Alnylam Pharmaceuticals, Inc.'s latest annual total debt in 2023 was 2.39 Billion USD , up 2.68% from previous year.
  • Alnylam Pharmaceuticals, Inc.'s latest quarterly total debt in 2024 Q2 was 2.42 Billion USD , down -9.58% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported annual total debt of 2.61 Billion USD in 2022, up 19.53% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported annual total debt of 2.18 Billion USD in 2021, up 37.23% from previous year.
  • Alnylam Pharmaceuticals, Inc. reported quarterly total debt of 2.49 Billion USD for 2024 Q3, up 2.59% from previous quarter.
  • Alnylam Pharmaceuticals, Inc. reported quarterly total debt of 2.42 Billion USD for 2024 Q2, down -9.58% from previous quarter.

Annual Total Debt Chart of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Historical Annual Total Debt of Alnylam Pharmaceuticals, Inc. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 2.39 Billion USD 2.68%
2022 2.61 Billion USD 19.53%
2021 2.18 Billion USD 37.23%
2020 1.59 Billion USD 424.23%
2019 303.82 Million USD 912.74%
2018 30 Million USD 0.0%
2017 30 Million USD -80.0%
2016 150 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Total Debt Comparison of Alnylam Pharmaceuticals, Inc.

Name Total Debt Total Debt Difference
Editas Medicine, Inc. 36.53 Million USD -6463.431%
Dynavax Technologies Corporation 256.91 Million USD -833.392%
Supernus Pharmaceuticals, Inc. 41.52 Million USD -5674.592%
Perrigo Company plc 4.07 Billion USD 41.13%
Illumina, Inc. 2.26 Billion USD -6.013%
Thermo Fisher Scientific Inc. 34.91 Billion USD 93.132%
Iovance Biotherapeutics, Inc. 1 Million USD -239701.5%
Walgreens Boots Alliance, Inc. 9.55 Billion USD 74.9%
IQVIA Holdings Inc. 14.23 Billion USD 83.149%
Heron Therapeutics, Inc. 173.75 Million USD -1280.129%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 11.28%
Unity Biotechnology, Inc. 26.99 Million USD -8784.828%
Waters Corporation 2.35 Billion USD -1.804%
Biogen Inc. 7.33 Billion USD 67.321%
Sangamo Therapeutics, Inc. 38.1 Million USD -6193.342%
Evolus, Inc. 126.54 Million USD -1794.975%
Adicet Bio, Inc. 17.7 Million USD -13445.811%
Cara Therapeutics, Inc. 43.16 Million USD -5455.204%
bluebird bio, Inc. 330.32 Million USD -625.954%
Esperion Therapeutics, Inc. 540.94 Million USD -343.299%
FibroGen, Inc. 170.45 Million USD -1306.832%
Agilent Technologies, Inc. 2.73 Billion USD 12.321%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD -11382.419%
Homology Medicines, Inc. 44.05 Million USD -5343.354%
Geron Corporation 85.89 Million USD -2691.668%
Amicus Therapeutics, Inc. 445.05 Million USD -438.808%
Myriad Genetics, Inc. 145 Million USD -1553.803%
Viking Therapeutics, Inc. 1.26 Million USD -190218.651%
Intellia Therapeutics, Inc. 115.34 Million USD -1978.975%
Zoetis Inc. 6.8 Billion USD 64.751%
Abeona Therapeutics Inc. 4.4 Million USD -54375.579%
Mettler-Toledo International Inc. 2.16 Billion USD -10.621%
BioMarin Pharmaceutical Inc. 1.13 Billion USD -111.488%
Vertex Pharmaceuticals Incorporated 808.4 Million USD -196.637%
Kala Pharmaceuticals, Inc. 36.32 Million USD -6501.919%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD -64.978%
Atara Biotherapeutics, Inc. 57.87 Million USD -4043.653%
Verastem, Inc. 41.55 Million USD -5670.424%
Nektar Therapeutics 230.4 Million USD -940.801%
Axsome Therapeutics, Inc. 186.37 Million USD -1186.682%
Aclaris Therapeutics, Inc. 3.07 Million USD -77909.597%
Sarepta Therapeutics, Inc. 1.39 Billion USD -71.678%
OPKO Health, Inc. 326.56 Million USD -634.317%
Exelixis, Inc. 189.94 Million USD -1162.485%
Neurocrine Biosciences, Inc. 428.4 Million USD -459.761%
Corcept Therapeutics Incorporated 151 Thousand USD -1587989.404%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 138.4 Million USD -1632.557%
Imunon, Inc. 1.13 Million USD -210382.729%
Blueprint Medicines Corporation 774.12 Million USD -209.772%
Insmed Incorporated 1.2 Billion USD -99.172%
Halozyme Therapeutics, Inc. 1.49 Billion USD -59.948%
Agios Pharmaceuticals, Inc. 56.98 Million USD -4107.93%
TG Therapeutics, Inc. 110.79 Million USD -2064.371%
Incyte Corporation 38.28 Million USD -6163.262%
Emergent BioSolutions Inc. 877.5 Million USD -173.278%